Highlights

• Novel hybrid scale-attention architecture achieving 99.77% accuracy on brain tumor classification

• Adaptive multi-scale module with learned input-dependent fusion weights for handling tumor size variation

• Evidential deep learning framework providing calibrated uncertainty quantification from single forward pass

• External validation on independent dataset (99.90% accuracy) demonstrating robust cross-domain generalization

• Misclassified cases exhibit significantly elevated uncertainty, enabling reliable clinical decision support
